Results 111 to 120 of about 4,282,769 (355)

CAUSES OF DEATH;

open access: yesThe Professional Medical Journal, 2019
Objectives: The purpose behind this study was to determine the pattern of the causes of death in adult males - a perspective on autopsy. Study Design: Cross sectional study. Period: 2015 to 2016. Setting: Peoples Medical College Hospital, Nawabshah, Shaheed Benazirabad, Sindh, Pakistan.
Mohammad Ismail Salim Memon   +2 more
openaire   +2 more sources

Survivin and Aurora Kinase A control cell fate decisions during mitosis

open access: yesMolecular Oncology, EarlyView.
Aurora A interacts with survivin during mitosis and regulates its centromeric role. Loss of Aurora A activity mislocalises survivin, the CPC and BubR1, leading to disruption of the spindle checkpoint and triggering premature mitotic exit, which we refer to as ‘mitotic slippage’.
Hana Abdelkabir   +2 more
wiley   +1 more source

Causes of death in patients with extranodal cancer of unknown primary: searching for the primary site [PDF]

open access: gold, 2014
Matias Riihimäki   +3 more
openalex   +1 more source

The feeding and breeding ecology of little blue penguins (Eudyptula minor) from Tiritiri Matangi Island, New Zealand : a thesis submitted in partial fulfilment of the requirements for the degree of Master of Science in Conservation Ecology, Massey University [PDF]

open access: yes, 2006
At present the New Zealand populations of Little Blue Penguins (LBP: Eudyptula minor) are classified as 'Threatened' and in 'Gradual Decline' by the Department of Conservation. Effective conservation management of the North Island sub-species requires an
Geurts, Jacqueline Lee
core  

CDK11 inhibition induces cytoplasmic p21WAF1 splice variant by p53 stabilisation and SF3B1 inactivation

open access: yesMolecular Oncology, EarlyView.
CDK11 inhibition stabilises the tumour suppressor p53 and triggers the production of an alternative p21WAF1 splice variant p21L, through the inactivation of the spliceosomal protein SF3B1. Unlike the canonical p21WAF1 protein, p21L is localised in the cytoplasm and has reduced cell cycle‐blocking activity.
Radovan Krejcir   +12 more
wiley   +1 more source

Reduced vascular leakage correlates with breast carcinoma T regulatory cell infiltration but not with metastatic propensity

open access: yesMolecular Oncology, EarlyView.
A mouse model for vascular normalization and a human breast cancer cohort were studied to understand the relationship between vascular leakage and tumor immune suppression. For this, endothelial and immune cell RNAseq, staining for vascular function, and immune cell profiling were employed.
Liqun He   +8 more
wiley   +1 more source

Reviewing disease burden among rural Indian women [PDF]

open access: yes, 2004
The disease burden of rural Indian women is reviewed by utilizing the data from the 'Survey of Causes of Death (rural)' annual reports of Registrar General of India supplemented with National family health survey (NFHS-II).
Agnihotram V, Dr. Ramanakumar
core  

Liquid biopsy epigenetics: establishing a molecular profile based on cell‐free DNA

open access: yesMolecular Oncology, EarlyView.
Cell‐free DNA (cfDNA) fragments in plasma from cancer patients carry epigenetic signatures reflecting their cells of origin. These epigenetic features include DNA methylation, nucleosome modifications, and variations in fragmentation. This review describes the biological properties of each feature and explores optimal strategies for harnessing cfDNA ...
Christoffer Trier Maansson   +2 more
wiley   +1 more source

It’s time we made smoking history! Tobacco control in Malta : the present and the future [PDF]

open access: yes, 1999
Tobacco products have no safe level of consumption. They are the only legal consumer products that cause ill health and premature death when used exactly as the manufacturer intends.
Sammut, Mario R.
core  

Improving PARP inhibitor efficacy in bladder cancer without genetic BRCAness by combination with PLX51107

open access: yesMolecular Oncology, EarlyView.
Clinical trials on PARP inhibitors in urothelial carcinoma (UC) showed limited efficacy and a lack of predictive biomarkers. We propose SLFN5, SLFN11, and OAS1 as UC‐specific response predictors. We suggest Talazoparib as the better PARP inhibitor for UC than Olaparib.
Jutta Schmitz   +15 more
wiley   +1 more source

Home - About - Disclaimer - Privacy